Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: Friend or foe?
Aimin Jiang, Na Liu, Jingjing Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16

Showing 16 citing articles:

The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases
Antero Salminen
Journal of Molecular Medicine (2024) Vol. 102, Iss. 6, pp. 733-750
Open Access | Times Cited: 22
Immune Checkpoints and the Immunology of Liver Fibrosis
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis
Livers (2025) Vol. 5, Iss. 1, pp. 5-5
Open Access | Times Cited: 1
Cooperation between inhibitory immune checkpoints of senescent cells with immunosuppressive network to promote immunosenescence and the aging process
Antero Salminen
Ageing Research Reviews (2025), pp. 102694-102694
Open Access | Times Cited: 1
Pharmacological targeting of ECM homeostasis, fibroblast activation, and invasion for the treatment of pulmonary fibrosis
Ioannis Tomos, Paraskevi Kanellopoulou, Dimitris Nastos, et al.
Expert Opinion on Therapeutic Targets (2025)
Closed Access | Times Cited: 1
Emerging role of immune cells as drivers of pulmonary fibrosis
Steven E. Mutsaers, Tylah Miles, Cecilia M. Prêle, et al.
Pharmacology & Therapeutics (2023) Vol. 252, pp. 108562-108562
Closed Access | Times Cited: 22
PD-1/PD-L1 axis in organ fibrosis
Youliang Zhao, Yaqian Qu, Changfu Hao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis
Τheodoros Karampitsakos, Apostolos Galaris, Serafeim Chrysikos, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 16
Advancing the Boundaries of Immunotherapy in Lung Adenocarcinoma with Idiopathic Pulmonary Fibrosis by a Biomimetic Proteinoid Enabling Selective Endocytosis
Aimin Jiang, Xiaoqiang Zheng, Siqi Yan, et al.
ACS Nano (2024)
Open Access | Times Cited: 4
Pulmonary fibrosis: pathogenesis and therapeutic strategies
Jianhai Wang, Kuan Li, De Hao, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 4
Single-cell transcriptomics reveals CD8+ T cell structure and developmental trajectories in idiopathic pulmonary fibrosis
Xuemei Wei, Chengji Jin, Dewei Li, et al.
Molecular Immunology (2024) Vol. 172, pp. 85-95
Open Access | Times Cited: 3
Inhibitory immune checkpoints suppress the surveillance of senescent cells promoting their accumulation with aging and in age-related diseases
Antero Salminen
Biogerontology (2024) Vol. 25, Iss. 5, pp. 749-773
Open Access | Times Cited: 3
PD-1 immunology in the kidneys: a growing relationship
Ruyue Chen, Qiang Lin, Hanyun Tang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
What role does PDL1 play in EMT changes in tumors and fibrosis?
Yun-Chao Zhang, Yuting Zhang, Yi Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Time-series transcriptome analysis mapping pulmonary immune checkpoint atlas of experimental silicosis
Youliang Zhao, Yuanmeng Qi, Meixiu Duan, et al.
Genes & Diseases (2024) Vol. 12, Iss. 1, pp. 101258-101258
Open Access
What Is on the Horizon for Treatments in Idiopathic Pulmonary Fibrosis?
Teng Moua, Misbah Baqir, Jay H. Ryu
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6304-6304
Open Access
Interstitial lung diseases with concomitant lung cancer: a data mining approach revealing a complex condition with gender- and immune-associated specific implications
Fabio Massimo Perrotta, Donato Lacedonia, Vito D’Agnano, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Page 1

Scroll to top